TrialMolecules (Basel, Switzerland)2021

Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia.

Robert Krysiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.